PuSH - Publikationsserver des Helmholtz Zentrums München

Schröder, A.* ; Lunding, L.P.* ; Zissler, U.M. ; Vock, C.* ; Webering, S.* ; Ehlers, J.C.* ; Orinska, Z.* ; Chaker, A. ; Schmidt-Weber, C.B. ; Lang, N.J. ; Schiller, H. B. ; Mall, M.A.* ; Fehrenbach, H.* ; Dinarello, C.A.* ; Wegmann, M.*

IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33.

Allergy, DOI: 10.1111/all.15072 (2022)
Verlagsversion DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
BACKGROUND: Children with asthma have impaired production of interleukin (IL) 37; in mice IL-37 reduces hallmarks of experimental allergic asthma (EAA). However, it remains unclear how IL-37 exerts its inhibitory properties in asthma. This study aimed to identify the mechanism(s) by which IL-37 controls allergic inflammation. METHODS: IL-37 target cells were identified by single-cell RNA-seq of IL-1R5 and IL-1R8. Airway tissues were isolated by laser capture microdissection and examined by microarray-based gene expression analysis. Mononuclear cells (MNC) and airway epithelial cells (AECs) were isolated and stimulated with allergen, IL-1β or IL-33 together with recombinant human (rh) IL-37. Wild-type, IL-1R1- and IL-33-deficient mice with EAA were treated with rhIL-37. IL-1β, IL-33, and IL-37 levels were determined in sputum and nasal secretions from adult asthma patients without glucocorticoid-therapy. RESULTS: IL-37 target cells included AECs, T cells, and dendritic cells. In mice with EAA, rhIL-37 led to differential expression of >90 genes induced by IL-1β and IL-33. rhIL-37 reduced production of Th2 cytokines in allergen-activated MNCs from wild-type but not from IL-1R1-deficient mice, and inhibited IL-33-induced Th2 cytokine release. Furthermore, rhIL-37 attenuated IL-1β- and IL-33-induced pro-inflammatory mediator expression in murine AEC cultures. In contrast to wild-type mice, hIL-37 had no effect on EAA in IL-1R1- or IL-33-deficient mice. We also observed that expression/production ratios of both IL-1β and IL-33 to IL-37 were dramatically increased in asthma patients compared to healthy controls. CONCLUSION: IL-37 down-regulates allergic airway inflammation by counterbalancing the disease-amplifying effects of IL-1β and IL-33.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Asthma ; Asthma Treatment ; Inflammation ; Interleukin; Airway Epithelial-cells; Asthma Phenotypes; Tnf-alpha; Cluster-analysis; T-cells; Expression; Cytokines; Helper; Interleukin-1; Receptor
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
German Center for Lung Research (DZL)
Förderungen Bundesministerium für Bildung und Forschung
National Institutes of Health
Deutsche Forschungsgemeinschaft
Deutsche Zentrum für Lungenforschung